375 related articles for article (PubMed ID: 23604648)
1. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: A multicenter retrospective study.
Lee KJ; Yoo JJ; Oh KJ; Yoo JH; Rhyu KH; Nam KW; Suh DH
Injury; 2017 Apr; 48(4):941-945. PubMed ID: 28274470
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
6. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
7. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
Grady MK; Watson JT; Cannada LK
Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
[TBL] [Abstract][Full Text] [Related]
8. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
9. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
[TBL] [Abstract][Full Text] [Related]
10. Atypical femoral fractures related to bisphosphonate use: A comprehensive review of 19 patients.
Şahin K; Ergin ON; Bayram S; Akgül T
Ulus Travma Acil Cerrahi Derg; 2019 Nov; 25(6):603-610. PubMed ID: 31701502
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment improves clinical and functional outcomes for patients who sustain incomplete bisphosphonate-related femur fractures.
Egol KA; Park JH; Prensky C; Rosenberg ZS; Peck V; Tejwani NC
J Orthop Trauma; 2013 Jun; 27(6):331-5. PubMed ID: 22986315
[TBL] [Abstract][Full Text] [Related]
12. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
Ha YC; Cho MR; Park KH; Kim SY; Koo KH
Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
[TBL] [Abstract][Full Text] [Related]
13. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
Bögl HP; Aspenberg P; Schilcher J
Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
[TBL] [Abstract][Full Text] [Related]
14. Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.
Sasaki S; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2012 Sep; 30(5):561-7. PubMed ID: 22610061
[TBL] [Abstract][Full Text] [Related]
15. Healing Time and Complications in Operatively Treated Atypical Femur Fractures Associated With Bisphosphonate Use: A Multicenter Retrospective Cohort.
Bogdan Y; Tornetta P; Einhorn TA; Guy P; Leveille L; Robinson J; Bosse MJ; Haines N; Horwitz D; Jones C; Schemitsch E; Sagi C; Thomas B; Stahl D; Ricci W; Brady M; Sanders D; Kain M; Higgins TF; Collinge C; Kottmeier S; Friess D
J Orthop Trauma; 2016 Apr; 30(4):177-81. PubMed ID: 26709814
[TBL] [Abstract][Full Text] [Related]
16. Atypical femur fractures in patients receiving bisphosphonate therapy: etiology and management.
Blum L; Cummings K; Goulet JA; Perdue AM; Mauffrey C; Hake ME
Eur J Orthop Surg Traumatol; 2016 May; 26(4):371-7. PubMed ID: 26943872
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of bone-end intervention on fracture healing in bisphosphonate-related atypical femoral fractures.
Canbek U; Akgun U; Aydogan NH
Orthop Traumatol Surg Res; 2020 Feb; 106(1):77-83. PubMed ID: 31784413
[TBL] [Abstract][Full Text] [Related]
18. Nonunions of Bisphosphonate Fractures of the Femur: Presentation, Etiopathogenesis, Diagnosis, and Operative Treatment.
Leighton RK; de Dios Robinson J; Giannoudis PV
J Orthop Trauma; 2019 Dec; 33 Suppl 8():S14-S20. PubMed ID: 31688522
[TBL] [Abstract][Full Text] [Related]
19. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
20. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.
Banffy MB; Vrahas MS; Ready JE; Abraham JA
Clin Orthop Relat Res; 2011 Jul; 469(7):2028-34. PubMed ID: 21350886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
